IE39537L - Substituted 16,17,18,19,20, -pentanor-prostaglandins - Google Patents

Substituted 16,17,18,19,20, -pentanor-prostaglandins

Info

Publication number
IE39537L
IE39537L IE732002A IE200273A IE39537L IE 39537 L IE39537 L IE 39537L IE 732002 A IE732002 A IE 732002A IE 200273 A IE200273 A IE 200273A IE 39537 L IE39537 L IE 39537L
Authority
IE
Ireland
Prior art keywords
phenoxy
oxo
trans
pentanor
prostaglandins
Prior art date
Application number
IE732002A
Other versions
IE39537B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IE55973A priority Critical patent/IE39538B1/en
Priority to IE560/77A priority patent/IE39539B1/en
Publication of IE39537L publication Critical patent/IE39537L/en
Publication of IE39537B1 publication Critical patent/IE39537B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1456512 Silylated oxaprostaglandins PFIZER Inc 7 Nov 1973 [8 Nov 1972] 51758/73 Heading C3S [Also in Division C2] Dimethylisopropylsilyl 9 - oxo - 11α,15α - bis- (dimethylisopropylsilyloxy) - 16 - phenoxy - 17, 18,19,20 - tetra - nor - trans - 13 - prostenoate is prepared by hydrogenating dimethylisopropylsilyl 9 - oxo - 11α,15α - bis - (dimethylisopropylsilyloxy) - 16 - phenoxy - 17,18,19,20 - tetranorcis - S, trans - 13 - prostadienoate, obtained by reacting 9 - oxo - 11α,15α - dihydroxy - 16- phenoxy - 17,18,19,20 - tetranor - cis - S, trans- 13-prostadienoic acid with dimethylisopropylchlorosilane. [GB1456512A]
IE2002/73A 1972-11-08 1973-11-07 Substituted 16,17,18,19,20-pentanor-prostaglandins IE39537B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE55973A IE39538B1 (en) 1972-11-08 1973-11-07 Derivatives of cyclopentanecetic acid
IE560/77A IE39539B1 (en) 1972-11-08 1973-11-07 Substituted dialkyl-2-oxopropylphonates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (2)

Publication Number Publication Date
IE39537L true IE39537L (en) 1974-05-08
IE39537B1 IE39537B1 (en) 1978-11-08

Family

ID=23178133

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2002/73A IE39537B1 (en) 1972-11-08 1973-11-07 Substituted 16,17,18,19,20-pentanor-prostaglandins

Country Status (29)

Country Link
JP (3) JPS5416491B2 (en)
AR (3) AR200585A1 (en)
AT (3) AT367034B (en)
AU (1) AU470375B2 (en)
BE (1) BE806995A (en)
CA (3) CA1085831A (en)
CH (1) CH597176A5 (en)
CS (3) CS182793B2 (en)
DD (4) DD118856A5 (en)
DE (1) DE2355540C2 (en)
DK (1) DK144247C (en)
ES (3) ES420325A1 (en)
FI (1) FI60389C (en)
FR (3) FR2205335B1 (en)
GB (3) GB1456513A (en)
HK (3) HK27979A (en)
HU (3) HU172703B (en)
IE (1) IE39537B1 (en)
IL (1) IL43589A (en)
IN (1) IN139384B (en)
KE (3) KE2930A (en)
MY (3) MY7900246A (en)
NL (1) NL164273C (en)
NO (3) NO147836C (en)
PH (3) PH13272A (en)
SE (4) SE448992B (en)
SU (4) SU584766A3 (en)
YU (3) YU39715B (en)
ZA (1) ZA738554B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
GB1506817A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
ES449162A1 (en) * 1975-06-23 1977-12-16 Syntex Inc A PROCEDURE FOR THE PREPARATION OF A RACEMI-CO U 8R-ANTIMERIC COMPOUND.
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (en) * 1977-12-12 1979-06-13 Upjohn Co USE OF PROSTAGLAND TYPE AMIDES TO CONTROL OR REGULATE THE REPRODUCTION CYCLE IN INDIVIDUALS OF MAMMALS
DK523378A (en) * 1978-01-16 1979-07-17 Pfizer PROCEDURE FOR THE PREPARATION OF N- (TETRAZOL-5-YL) PROSTAGLANDIN CARBOXAMIDES OR SALTS THEREOF
ID24845A (en) * 1997-09-09 2000-08-24 Procter & Gamble AROMATIC C16-C20 SUBSTITUTED PROSTAGLANDIN PROSTAGLANDIN USED AS A FP AGONIST
CA2364948C (en) 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
JP2002329615A (en) * 2001-05-02 2002-11-15 Ohira Denshi Kk Toroidal coil
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
WO2006047466A2 (en) 2004-10-21 2006-05-04 Duke University Ophthamological drugs
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
CS182791B2 (en) 1978-05-31
DD118856A5 (en) 1976-03-20
PH13110A (en) 1979-11-28
IL43589A0 (en) 1974-03-14
MY7900246A (en) 1979-12-31
HK28079A (en) 1979-05-11
NO149139B (en) 1983-11-14
GB1456513A (en) 1976-11-24
NO149139C (en) 1984-02-29
AT360672B (en) 1981-01-26
DD109212A5 (en) 1974-10-20
KE2932A (en) 1979-03-30
SE445111B (en) 1986-06-02
HU172703B (en) 1978-11-28
AR199966A1 (en) 1974-10-08
HU173507B (en) 1979-05-28
MY7900243A (en) 1979-12-31
FR2279729A1 (en) 1976-02-20
DE2355540C2 (en) 1982-11-18
CA1088930A (en) 1980-11-04
IN139384B (en) 1976-06-12
NO148998C (en) 1984-01-25
NO147836C (en) 1983-06-22
FI60389C (en) 1982-01-11
BE806995A (en) 1974-05-07
ES433047A1 (en) 1976-11-01
DE2365322A1 (en) 1974-11-07
PH13272A (en) 1980-02-27
DK144247B (en) 1982-01-25
SE7700717L (en) 1977-01-24
NL7315263A (en) 1974-05-10
NO750535L (en) 1974-05-09
GB1456512A (en) 1976-11-24
AU6224773A (en) 1975-05-08
YU288073A (en) 1982-02-28
YU37316B (en) 1984-08-31
FR2279729B1 (en) 1978-04-28
AT353285B (en) 1979-11-12
YU270780A (en) 1982-06-18
FR2205335A1 (en) 1974-05-31
JPS5416491B2 (en) 1979-06-22
NO147836B (en) 1983-03-14
ES433046A1 (en) 1977-06-16
DE2365322B2 (en) 1977-02-24
ZA738554B (en) 1974-09-25
CH597176A5 (en) 1978-03-31
ATA544676A (en) 1979-04-15
SE7700718L (en) 1977-01-24
NO743493L (en) 1974-05-09
HK28179A (en) 1979-05-11
CA1085831A (en) 1980-09-16
SU584766A3 (en) 1977-12-15
CS182793B2 (en) 1978-05-31
MY7900245A (en) 1979-12-31
AU470375B2 (en) 1976-03-11
HU171819B (en) 1978-03-28
KE2931A (en) 1979-03-30
FI60389B (en) 1981-09-30
YU39715B (en) 1985-04-30
KE2930A (en) 1979-03-30
SE431756B (en) 1984-02-27
FR2205335B1 (en) 1978-07-13
AR202931A1 (en) 1975-07-31
JPS4993342A (en) 1974-09-05
FR2283146B1 (en) 1981-06-19
GB1456514A (en) 1976-11-24
DD117233A5 (en) 1976-01-05
NO148998B (en) 1983-10-17
AR200585A1 (en) 1974-11-22
SU893130A3 (en) 1981-12-23
YU270680A (en) 1983-04-27
SU667141A3 (en) 1979-06-05
ES420325A1 (en) 1976-04-16
FR2283146A1 (en) 1976-03-26
IE39537B1 (en) 1978-11-08
DD119411A5 (en) 1976-04-20
DK144247C (en) 1982-07-12
JPS5257147A (en) 1977-05-11
YU36975B (en) 1984-08-31
ATA544576A (en) 1980-06-15
ATA936973A (en) 1981-10-15
SE7700716L (en) 1977-01-24
CA1088931A (en) 1980-11-04
IL43589A (en) 1980-01-31
AT367034B (en) 1982-05-25
SE436278B (en) 1984-11-26
SU745362A3 (en) 1980-06-30
CS182794B2 (en) 1978-05-31
DE2355540A1 (en) 1974-05-22
JPS5253841A (en) 1977-04-30
SE448992B (en) 1987-03-30
PH13325A (en) 1980-03-13
HK27979A (en) 1979-05-11
NL164273C (en) 1980-12-15

Similar Documents

Publication Publication Date Title
IE39537B1 (en) Substituted 16,17,18,19,20-pentanor-prostaglandins
GB1436872A (en) X-ray source
GB1448413A (en) Prostaglandins and the manufacture therof
IE39078L (en) Substituted 1,3,5 - triazines.
GB1456838A (en) 16,17,18,19,20-pentanorprostaglandins
CA993663A (en) Crop conditioners
IE37909B1 (en) 15-substituted-omega-pentanorprostaglandins
IE40217L (en) Preparation of chlorinated phenyl-hydroxylamines.
CA1014564A (en) Derivatives of 1,3-benzodioxole-2-carboxylic acid
CA1028699A (en) Prostanoic acid derivatives
IE37717L (en) N-BENZHYDRYL-N'-p-HYDROXYBENZYL-PIPERAZINES.
CA1005171A (en) Bipolar transistor construction method
IE36597L (en) Preparing a 1,2-dihydrophthalazine
CA1000873A (en) Bipolar transistor construction method
IE35985L (en) Penicillanic acid derivatives
IE35821L (en) Pyrrolidinyl-sulphamoylbenzamide derivatives
GB1397189A (en) Acid-modified polyterephthalic acid esters
AU474650B2 (en) An improved fastener for building constructs
AU460497B2 (en) 8d, 12 p PROSTAGLANDIN DERIVATIVES
AU481458B2 (en) Double diffused, lateral transistor structure
IE40172L (en) Acylamino - phenyl - acetamidine anthelmintics
AU482077B2 (en) Prostanoic acid derivatives
IE39813L (en) 7-H-INDOLIZINO [5,6,7-ij] ISOQUINOLINE DERIVATIVES.
CA873373A (en) Cyclohexa-1,4-diene-1-acetic acid
CA1016943A (en) Method for the production of 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine